32种口服抗精神病药物用于多发作型精神分裂症成人急性治疗的疗效和耐受性比较：一项系统评价和网状Meta分析
Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis.
作者信息
Huhn Maximilian, Nikolakopoulou Adriani, Schneider-Thoma Johannes, Krause Marc, Samara Myrto, Peter Natalie, Arndt Thomas, Bäckers Lio, Rothe Philipp, Cipriani Andrea, Davis John, Salanti Georgia, Leucht Stefan
出版信息
Focus (Am Psychiatr Publ). 2020 Oct;18(4):443-455. doi: 10.1176/appi.focus.18306. Epub 2020 Nov 5.
Abstract
(Reprinted with permission from the 2019; 394: 939-51).
摘要
（经许可重印自《2019年；394：939 - 51》）
相似文献
1
Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults With Multi-Episode Schizophrenia: A Systematic Review and Network Meta-Analysis.32种口服抗精神病药物用于多发作型精神分裂症成人急性治疗的疗效和耐受性比较：一项系统评价和网状Meta分析
Focus (Am Psychiatr Publ). 2020 Oct;18(4):443-455. doi: 10.1176/appi.focus.18306. Epub 2020 Nov 5.
2
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.21种抗抑郁药物治疗成人重度抑郁症急性发作的疗效与可接受性比较：一项系统评价与网状Meta分析
Focus (Am Psychiatr Publ). 2018 Oct;16(4):420-429. doi: 10.1176/appi.focus.16407. Epub 2018 Oct 18.
3
Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.儿童和青少年精神分裂症谱系障碍的急性抗精神病治疗：系统评价和网络荟萃分析。
J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):191-202. doi: 10.1016/j.jaac.2016.12.013. Epub 2016 Dec 29.
4
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses.抗精神病药物治疗精神分裂症的急性疗效：近期荟萃分析综述
Ther Adv Psychopharmacol. 2018 Oct 8;8(11):303-318. doi: 10.1177/2045125318781475. eCollection 2018 Nov.
5
Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.最大限度提高精神分裂症一线抗精神病药物的反应：一项基于荟萃分析结果的综述。
Psychopharmacology (Berl). 2019 Feb;236(2):545-559. doi: 10.1007/s00213-018-5133-z. Epub 2018 Nov 30.
6
Antipsychotic drugs for the acute treatment of patients with a first episode of schizophrenia: a systematic review with pairwise and network meta-analyses.抗精神病药物用于精神分裂症首发患者的急性治疗：一项采用成对和网状荟萃分析的系统评价
Lancet Psychiatry. 2017 Sep;4(9):694-705. doi: 10.1016/S2215-0366(17)30270-5. Epub 2017 Jul 20.
7
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.比较氨磺必利与其他非典型抗精神病药单药治疗青少年精神分裂症的系统文献评价和网络荟萃分析。
Eur Child Adolesc Psychiatry. 2020 Sep;29(9):1195-1205. doi: 10.1007/s00787-019-01425-2. Epub 2019 Nov 22.
8
A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia.系统评价汇总分析口服非典型抗精神病药物治疗成人精神分裂症的疗效。
Expert Opin Pharmacother. 2012 Aug;13(11):1545-73. doi: 10.1517/14656566.2011.626769. Epub 2011 Oct 17.
9
Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia.帕利哌酮缓释片与其他口服非典型抗精神病药物治疗精神分裂症的疗效及耐受性
Int J Clin Pharmacol Ther. 2010 Jun;48(6):383-99. doi: 10.5414/cpp48383.
10
Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.标准剂量与低剂量抗精神病药预防反复发作精神分裂症：系统评价和随机对照试验的荟萃分析。
Lancet Psychiatry. 2021 Jun;8(6):471-486. doi: 10.1016/S2215-0366(21)00078-X.
引用本文的文献
1
Should we be Prescribing Fluphenazine Long-Acting Injectable Formulation?我们应该开氟奋乃静长效注射剂吗？
Curr Psychiatry Rep. 2025 Apr 28. doi: 10.1007/s11920-025-01610-y.
2
New pharmacological approaches in the treatment of schizophrenia.精神分裂症治疗中的新药理学方法。
Pharmacol Rep. 2025 Jun;77(3):561-575. doi: 10.1007/s43440-025-00722-9. Epub 2025 Apr 8.
3
Mitochondrial Transplantation in Animal Models of Psychiatric Disorders: A Novel Approach to Psychiatric Treatment.精神疾病动物模型中的线粒体移植：一种精神疾病治疗的新方法。
Biomolecules. 2025 Jan 27;15(2):184. doi: 10.3390/biom15020184.
4
Medication Exposure and Mortality in Patients With Schizophrenia.精神分裂症患者的药物暴露与死亡率。
JAMA Netw Open. 2024 Nov 4;7(11):e2447137. doi: 10.1001/jamanetworkopen.2024.47137.
5
Antipsychotic prescription patterns among schizophrenia patients in Guangdong Province, China's 686 program: A retrospective study.中国“686 项目”中广东省精神分裂症患者的抗精神病药物处方模式：一项回顾性研究。
Medicine (Baltimore). 2024 Sep 13;103(37):e39629. doi: 10.1097/MD.0000000000039629.
6
Sublingual asenapine for agitation in malabsorptive states: three patient cases.舌下含服阿立哌唑治疗吸收不良状态下的激越：三例患者病例
Ther Adv Psychopharmacol. 2024 Jul 25;14:20451253241263714. doi: 10.1177/20451253241263714. eCollection 2024.
7
Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis.非侵入性脑刺激治疗抗药性精神分裂症：系统评价和网络荟萃分析方案。
Syst Rev. 2024 Jun 24;13(1):165. doi: 10.1186/s13643-024-02585-2.
8
The patient journey project in Italian mental health services: results from a co-designed survey on clinical interventions and current barriers to improve the care of people living with schizophrenia.意大利精神卫生服务中的患者就医过程项目：一项关于临床干预措施及改善精神分裂症患者护理现状障碍的联合设计调查结果
Front Psychiatry. 2024 Mar 28;15:1382326. doi: 10.3389/fpsyt.2024.1382326. eCollection 2024.
9
Relationship between functional connectivity and weight-gain risk of antipsychotics in schizophrenia.精神分裂症中抗精神病药物的功能连接与体重增加风险的关系。
Schizophr Res. 2024 May;267:173-181. doi: 10.1016/j.schres.2024.03.033. Epub 2024 Mar 28.
10
Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders.精神分裂症谱系障碍患者的住院抗精神病药物转换与再住院风险。
Schizophr Res. 2024 May;267:165-172. doi: 10.1016/j.schres.2024.03.034. Epub 2024 Mar 27.
Zotero 插件